Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
JANX holding history
Janux Therapeutics, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JANX overviewAll 13F holders of JANXFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −667,881−100.0% | Sold out | Holders |
| Q1 2025 | 667,881 | $18.0M | 0.1% | −599,922−47.3% | Reduced | Holders |
| Q4 2024 | 1,267,803 | $67.9M | 0.2% | +564,322+80.2% | Added | Holders |
| Q3 2024 | 703,481 | $32.0M | 0.1% | +874+0.1% | Added | Holders |
| Q2 2024 | 702,607 | $29.4M | 0.1% | +160,234+29.5% | Added | Holders |
| Q1 2024 | 542,373 | $20.4M | 0.1% | +542,373 | New | Holders |